Volume 21 - Issue 12 - December, 2009

Spontaneous Coronary Artery Dissection-A Diagnosis To Be Considered in Young Patients (Full title below)

‡Rafael Nogueira de Macedo, MD, ‡Samuel de Paula Miranda, MD,
*†Ricardo Leite Vieira da Costa, MD, MPH

Spontaneous Coronary Artery Dissection — A Diagnosis To Be Considered in Young Patients Presenting with Acute Myocardial Infarction

From the ‡Emergency Department, Hospital de Messejana, Fortaleza, Brazil, *Haemodynamics, Hospital Mont Klinikum, Fortaleza, Brazil, †Haemodynamics, Hospital de Messejana, Fortaleza, Brazil.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted April 1, 2009, provisional acceptance given April 27, 2009, final version accepted May 4, 2009.

Address for correspondence: Rafael N. Macedo, E...

Preprocedural Inflammation Does Not Affect Neointimal Hyperplasia following Everolimus-Eluting Stent Implantation

Daisaku Nakatani, MD, PhD, Junya Ako, MD, PhD, Masao Yamasaki, MD, PhD, Takao Shimohama, MD, PhD,
Takao Hasegawa, MD, Hiromasa Otake, MD, PhD, Katsuhisa Waseda, MD, PhD, Ichizo Tsujino, MD, PhD,
Ryota Sakurai, MD, Bon-Kwon Koo, MD, PhD, Hyeonsoo Chang, MSME, Paul G. Yock, MD,
*Krishnankutty Sudhir, MD, PhD, *Wesley Pierson, PhD, §Gregg W. Stone, MD, †Shigeru Saito, MD,
Yasuhiro Honda, MD, Peter J. Fitzgerald, MD, PhD

ABSTRACT: Background. Preprocedual C-reactive protein (CRP) has been reported to correlate with in-stent restenosis following bare-metal stent implantation. The aim of this study was to investigate the impact of preprocedural inflammation on neointimal hyperplasia assessed by intravascular ultrasound (IVUS) following everolimus-eluting stent (EES) implantation. Methods. We identified 134 patients meeting the following criteria: 1) patients treated with EES; 2) those with stable or unstable angina; and 3) patients available for high-sensitivity (hs)-CRP before the procedure and volumetric IVUS ...

Management of Guidewire-Induced Coronary Artery Perforations through Transradial Route-A Simple Approach

†Tejas Patel, MD, Sanjay Shah, MD,
Indra Kuladhipati, MD

From the †Total Cardiovascular Solutions Private Limited, and Sheth V.S.General Hospital, Ahmedabad, India.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted June 19, 2009, provisional acceptance given July 20, 2009, final version accepted August 3, 2009.

Address for correspondence: Tejas Patel, MD, FACC, FSCAI, Professor and Head, Department of Cardiology, Sheth V.S.General Hospital, Ahmedabad-380 006, India. E-mail: [email protected]



Validation of a Risk Score for Target Vessel Revascularization after Coronary Stent Implantation

aAlexandre S. Quadros, MD, PhD, bFabiane Diemer, RN, bDulce Welter, RN, Thais Modkovski, MD,
aRogério Sarmento-Leite, MD, PhD, aCarlos A.M. Gottschall, MD, PhD, FSCAI, FIAGS

ABSTRACT: Objective. Our aim was to validate a risk score for new target vessel revascularization (TVR) after bare-metal stent (BMS) implantation. Methods. The risk score was developed in a cohort of patients previously treated with BMS at our institution. This risk score ranges from 0 to 5 points, according to the presence of diabetes mellitus (1 point), reference vessel diameter (> 3.5 mm = 0 points; 3–3.5 mm = 1; 20 mm = 2). Patients included in the validation cohort were treated between January and December 2005. Pati...

Very Late Thrombosis of a Sirolimus-Eluting Stent after 57 Months

Anil Paturi, MD,* Mark Rothenberg, MD,* Steven Borzak, MD*§

From the *University of Miami Miller School of Medicine, and Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, and §Nova Southeastern College of Medicine, Ft. Lauderdale, Florida.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted May 29, 2009, provisional acceptance given June 24, 2009, final version accepted July 7, 2009.

Address for correspondence: Anil Paturi, MD, Internal Medicine Residency Program, JFK Medical Center, 4 South, 5301 S. Congress, Atlantis, FL 33462. E-mail: apaturi@me...

A Novel “In-Situ Tulip-Bud Deployment” Method for Transcatheter Closure of Secundum Atrial Septal Defect

Swee Chye Quek, MD, FRCPCH, Wen Xia Wu, MBBS, Kit Yee Chan, MD, Patrick Ang, MBBS, MRCP,
Ting Fei Ho, MD, FRCP, William Yip, MD, FRCP

ABSTRACT: Objective. We devised a new technique for interventional closure of atrial septal defect (ASD) using the Amplatzer Septal Occluder (ASO), and validated this by comparing it with a cohort using the conventional method. Background. Transcatheter closure of ASD is a widely accepted modality of treatment. Although the outcome is good, there are occasional technical difficulties encountered. Method. In this three-step technique, the device is protruded to form a “tulip bud.” This “tulip bud” is then aligned adjacent to and along the plane of the ASD. The second step involves withd...

Primary Antiphospholipid Syndrome with Recurrent Coronary Thrombosis, Acute Pulmonary Thromboembolism and Intracerebral Hematoma

Panduranga Prashanth, MD and Mohammed Khamis Mukhaini, FRCP(C)

From the Department of Cardiology, Royal Hospital, Muscat, Oman.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted May 21, 2009, provisional acceptance given June 8, 2009, final version accepted June 24, 2009.

Address for correspondence: Dr. Panduranga Prashanth, Department of Cardiology, Royal Hospital, Post Box 1331, Muscat-111, Oman. E-mail: [email protected]


ABSTRACT: We present a young patient with myocardial infarction who had rec...

Predictors of Distal Embolization in Peripheral Percutaneous Interventions: A Report from a Large Peripheral Vascular Registry

Nicolas W. Shammas, MD, MS, Gail A. Shammas, BS, RN, Eric J. Dippel, MD, Michael Jerin, PhD,
Waheeb J. Shammas

ABSTRACT: Background. Distal embolization (DE) commonly occurs during peripheral percutaneous interventions (PPI) of the lower-extremity arterial vessels. In this study we evaluate the predictors of DE in a large cohort of patients undergoing PPI at our center. Methods. Patients who experienced clinically significant DE (requiring further mechanical or pharmacologic therapy as per operator judgment) were extracted from a peripheral vascular registry that prospectively tracks demographics, clinical, procedural and outcome variables on patients undergoing PPI at our medical center and compared t...

Atheroemboli during Peripheral Arterial Interventions

Subhash Banerjee, MD, Tej Thatthi, BA, Neeraj Badhey, MD, Emmanouil S. Brilakis, MD, PhD

Atheroemboli during percutaneous peripheral arterial interventions (PAI) complicate about 1–2% of procedures, with serious adverse outcomes, although their true incidence is estimated to be much greater.1 In the era of increasing number and complexity of percutaneous peripheral arterial revascularization procedures, it is important to provide operators with guidance regarding the predictors of this rare though serious complication. The rarity and often unpredictability of atheroembolic complications during PAI makes this article by Shammas et al extremely relevant to today’s endovascular s...

Editorial Staff
  • Executive Officer
    Laurie Gustafson
  • Production
    Elizabeth Vasil
  • National Account Manager
    Jeff Benson
  • Senior Account Director
    Carson McGarrity
  • Special Projects Editor
    Amanda Wright
Editorial Correspondence

Back to top